Patent 7541331 was granted and assigned to Discovery Laboratories on June, 2009 by the United States Patent and Trademark Office.
Regimens for the therapeutic or prophylactic administration of pulmonary surfactant to infants exhibiting or at risk of developing bronchopulmonary dysplasia are disclosed.